CIBC Private Wealth Group
AVXL icon

CIBC Private Wealth Group’s Anavex Life Sciences AVXL Stock Holding History

CIBC Private Wealth Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,200
Closed -$11.1K – 3098
2025
Q2 		$11.1K Sell
1,200
-100
-8% -$854 ﹤0.01% 2210
2025
Q1 		$9.88K Sell
1,300
-200
-13% -$1.89K ﹤0.01% 2247
2024
Q4 		$17.1K Sell
1,500
-500
-25% -$3.85K ﹤0.01% 2116
2024
Q3 		$11.4K Hold
2,000
– – ﹤0.01% 2368
2024
Q2 		$9.02K Hold
2,000
– – ﹤0.01% 2331
2024
Q1 		$10K Buy
+2,000
New +$11.3K ﹤0.01% 2269
2018
Q3 		– Sell
-125
Closed – – 1028
2018
Q2 		$0 Hold
125
– – ﹤0.01% 1959
2018
Q1 		$0 Hold
125
– – ﹤0.01% 1935
2017
Q4 		$0 Buy
+125
New +$492 ﹤0.01% 1922

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CIBC Private Wealth Group's AVXL Position: Q3 2025 in Review

CIBC Private Wealth Group sold out of Anavex Life Sciences (AVXL) in Q3 2025, closing a stake of 1,200 shares — an estimated $11.1K sold.

CIBC Private Wealth Group first reported a position in AVXL in Q4 2017 and held it in 9 quarters. The position peaked at $17.1K in Q4 2024. 186 funds tracked by Wall St. Rank hold AVXL as of Q3 2025.

  • CIBC Private Wealth Group reported no remaining Anavex Life Sciences position as of Q3 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 1,200 Anavex Life Sciences shares in Q3 2025, an estimated $11.1K.
  • CIBC Private Wealth Group first reported a position in Anavex Life Sciences in Q4 2017 and held it in 9 quarters.
  • CIBC Private Wealth Group's Anavex Life Sciences position peaked at $17.1K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2025.

Based on CIBC Private Wealth Group's 13F filing for Q3 2025, filed 24 Nov 2025.